Table 2 Summary of univariable analysis of risk factors associated with mortality among patients with K. pneumoniae infections
Risk factor | Survivors (n = 39) | Non-survivors (n = 21) | OR (95% CI) | p |
|---|---|---|---|---|
Male sex | 20 (51.3) | 14 (66.7) | 0.53 (0.16-1.59) | 0.25 |
McCabe score | ||||
Rapidly fatal | 10 (25.6) | 5 (23.8) | 1.1 (0.32-3.79) | 0.15 |
Potentially fatal/Non fatal | 29 (74.4) | 16 (76.2) | ||
Charlson score ≥ 3 | 13 (33.3) | 10 (47.6) | 1.82 (0.62-5.38) | 0.28 |
Transplant receipt | 7 (17.9) | 6 (28.6) | 0.55 (0.16-1.91) | 0.35 |
Prior corticosteroid use | 24 (61.5) | 14 (66.7) | 0.80 (0.26-2.44) | 0.69 |
Prior surgery | 27 (69.2) | 10 (47.6) | 2.48 (0.83-7.39) | 0.10 |
Dialysis | 4 (10.3) | 8 (38.1) | 0.19 (0.05-0.72) | 0.01 |
ICU stay | 32 (82.1) | 20 (95.2) | 0.23 (0.03-1.99) | 0.15 |
APACHE II score, mean, on admission | 16.2 | 22.4 | 1.39 (−10.65-1.65) | 0.009 |
SOFA score, mean, on admission | 5.6 | 7.7 | 3.59 (−4.54 -0.27) | 0.08 |
Vasopressor drug use | 1 (2.6) | 6 (28.6) | 15.2 (1.68-137.15) | 0.006 |
Mechanical ventilation | 5 (12.8) | 7 (33.3) | 3.40 (0.92-12.55) | 0.09 |
Appropriate antibiotic therapy | 27 (69.2) | 11 (52.4) | 2.04 (0.68-6.11) | 0.19 |
Carbapenem resistance | 10 (25.6) | 10 (47.6) | 2.64 (0.86-8.07) | 0.085 |